The bad news comes from a study of 621 microbiologists in Maryland who received fresh vaccinations between 1994 and 2001 to protect them in their work. Only about 40, or just 6 per cent, were still immune from their earlier vaccinations.
"The study is, to the best of my knowledge, the only one since eradication which tries to look at the durability of immunity," says lead author Michael Sauri, director of the Occupational Medicine Clinic in Maryland. "It's showing us that after 20 years immunity is not going to be there."
In the US, for example, about 60 per cent of the population has had a smallpox vaccination. The study suggests that most of these people are now just as susceptible to smallpox as the 120 million born since the government halted vaccination in 1972.
That strengthens the case for pre-emptive immunisation, some experts think. "It adds to the argument that you can't count on any protection we thought we had," says Bill Bicknell of Boston University, a former commissioner of the Massachusetts Department of Public Health who has been arguing for mass vaccination since the anthrax attacks, in case terrorists try smallpox next.
He thinks that outbreaks would be much easier to contain if almost everyone is vaccinated. "I'm not saying you just go straight in and vaccinate the population-you'd do it steadily in stages," Bicknell says. Healthcare workers would be first, followed by volunteers screened to check they're healthy.
But extrapolating from figures from the last mass vaccination in 1968 suggests at least 180 people would die of complications. That's a high price to pay for protection against an attack that may never happen.
The Centers for Disease Control in Atlanta believes mass vaccination is unnecessary and it can deal with an outbreak through "ring vaccination" of people in the affected zone, plus their contacts. It says its contingency plans for dealing with a smallpox outbreak, which will be reviewed this month, assume that no one is immune anyway.
In Britain, where smallpox vaccination stopped in 1980, the Department of Health is taking the same approach. "We won't be relying on any current immunity of the population," says a spokesman.
Nevertheless, Harold Margolis, the CDC's chief adviser on smallpox preparedness, remains convinced that there are higher levels of immunity in the general population than the study suggests. "We don't know a lot about the determinants of long-term immunity," he says.
Previous studies earlier this century in England and in the US suggested that immunity could last 50 years or more, Margolis says. "It won't protect you against infection, but it might protect you from death." He also pins hopes on a 1990 Israeli study showing that antibodies against the virus last for decades.
Author: Andy Coghlan
More at: Maryland Medicine (Spring 2002 issue, p 44)
New Scientist issue: 1st June 2002
PLEASE MENTION NEW SCIENTIST AS THE SOURCE OF THIS STORY AND, IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO: http://www.newscientist.com
"These articles are posted on this site to give advance access to other authorised media who may wish to quote extracts as part of fair dealing with this copyrighted material. Full attribution is required, and if publishing online a link to www.newscientist.com is also required. Advance permission is required before any and every reproduction of each article in full - please contact firstname.lastname@example.org. Please note that all material is copyright of Reed Business Information Limited and we reserve the right to take such action as we consider appropriate to protect such copyright."
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.